retatrutide triple agonist obesity trial Retatrutide—A Game Changer in Pharmacotherapy New obesity drugs are coming,

These include increasing redness that spreads beyond the injection site, warmth and tenderness that worsens rather than improves over 24-48 hours, pus or drainage from the injection site, red streaks extending from the site, and fever or chills following injection

Top concerns with using GLP-1s for weight loss are predatory pharmaceutical marketing practices (70%), supply chain issues for diabetes patients (63%), and prescribing behavior

The efficacy of these medications is much greater than anything that has been available up to this point

Whether youre taking these medications, considering them, or simply feeling confused about all the hype, I want to open up the conversation and help make it less overwhelming, and quite frankly, shame-free